Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-31
2010-06-08
Chu, Yong (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S452000, C548S512000
Reexamination Certificate
active
07732480
ABSTRACT:
There are disclosed bicyclic compounds according to formula I, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of androgen receptor-associated conditions, such as age-related diseases, for example sarcopenia,wherein R1, R2, R5, X and n are defined herein.
REFERENCES:
patent: 3239345 (1966-03-01), Hodge et al.
patent: 3948933 (1976-04-01), Fontanella
patent: 4036979 (1977-07-01), Asato
patent: 4411890 (1983-10-01), Momany et al.
patent: 4959361 (1990-09-01), Walser et al.
patent: 5179080 (1993-01-01), Rothkopf et al.
patent: 5403817 (1995-04-01), Seckinger et al.
patent: 5482921 (1996-01-01), Seckinger et al.
patent: 5488064 (1996-01-01), Sher et al.
patent: 5491134 (1996-02-01), Sher et al.
patent: 5541204 (1996-07-01), Sher et al.
patent: 5556909 (1996-09-01), Desai
patent: 5605877 (1997-02-01), Schafer et al.
patent: 5612359 (1997-03-01), Murugesan
patent: 5688808 (1997-11-01), Jones et al.
patent: 5688810 (1997-11-01), Jones et al.
patent: 5693646 (1997-12-01), Jones et al.
patent: 5693647 (1997-12-01), Jones et al.
patent: 5696127 (1997-12-01), Jones et al.
patent: 5696130 (1997-12-01), Jones et al.
patent: 5696133 (1997-12-01), Jones et al.
patent: 5770615 (1998-06-01), Cheng et al.
patent: 5776983 (1998-07-01), Washburn et al.
patent: 5811374 (1998-09-01), Bertram et al.
patent: 6011029 (2000-01-01), Ding et al.
patent: 6040321 (2000-03-01), Kim et al.
patent: 6043265 (2000-03-01), Merugusan et al.
patent: 6184231 (2001-02-01), Hewawasam et al.
patent: 6310095 (2001-10-01), Sebti et al.
patent: 6365615 (2002-04-01), Kelly et al.
patent: 6531612 (2003-03-01), Gabriel et al.
patent: 6566367 (2003-05-01), Bakthavatchalam et al.
patent: 6670386 (2003-12-01), Sun et al.
patent: 6710064 (2004-03-01), Launay et al.
patent: 6897225 (2005-05-01), Sircar et al.
patent: 6974823 (2005-12-01), Hamilton
patent: 6992102 (2006-01-01), Hamann et al.
patent: 7256208 (2007-08-01), Bi et al.
patent: 2002/0133004 (2002-09-01), Sekiyama et al.
patent: 2004/0019063 (2004-01-01), Sun et al.
patent: 2004/0181064 (2004-09-01), Sun et al.
patent: 2005/0059652 (2005-03-01), Hamann et al.
patent: 2005/0182105 (2005-08-01), Nirschl et al.
patent: 2005/0187267 (2005-08-01), Hamann et al.
patent: 2005/0197359 (2005-09-01), Nirschl et al.
patent: 2005/0197367 (2005-09-01), Li et al.
patent: 2007/0004717 (2007-01-01), Li et al.
patent: A-82875/87 (1998-06-01), None
patent: 2126187 (1971-05-01), None
patent: 3809390 (1989-09-01), None
patent: 0272594 (1988-06-01), None
patent: 0493323 (1992-07-01), None
patent: 1004583 (2000-05-01), None
patent: 1125925 (2001-08-01), None
patent: 1503244 (1978-03-01), None
patent: 52083686 (1977-07-01), None
patent: WO8907110 (1989-08-01), None
patent: WO8907111 (1989-08-01), None
patent: WO9304081 (1993-03-01), None
patent: WO9405668 (1994-03-01), None
patent: WO9414817 (1994-07-01), None
patent: WO9619458 (1996-06-01), None
patent: WO9719086 (1997-05-01), None
patent: WO9721993 (1997-06-01), None
patent: WO9730992 (1997-08-01), None
patent: WO9749709 (1997-12-01), None
patent: WO9822461 (1998-05-01), None
patent: WO9825929 (1998-06-01), None
patent: WO9838192 (1998-09-01), None
patent: WO9854966 (1998-12-01), None
patent: WO9900353 (1999-01-01), None
patent: WO9901124 (1999-01-01), None
patent: WO9902224 (1999-01-01), None
patent: WO9902514 (1999-01-01), None
patent: WO9903848 (1999-01-01), None
patent: WO9907692 (1999-02-01), None
patent: WO9924416 (1999-05-01), None
patent: WO9927890 (1999-06-01), None
patent: WO9928324 (1999-06-01), None
patent: WO9943653 (1999-09-01), None
patent: WO9954318 (1999-10-01), None
patent: WO9954319 (1999-10-01), None
patent: WO9954330 (1999-10-01), None
patent: WO9965913 (1999-12-01), None
patent: WO9967252 (1999-12-01), None
patent: WO9967253 (1999-12-01), None
patent: WO0000485 (2000-01-01), None
patent: WO0001389 (2000-01-01), None
patent: WO0013508 (2000-03-01), None
patent: WO0059874 (2000-10-01), None
patent: WO0072845 (2000-12-01), None
patent: WO0116108 (2001-03-01), None
patent: WO0116133 (2001-03-01), None
patent: WO0116139 (2001-03-01), None
patent: WO0130781 (2001-05-01), None
patent: WO0146195 (2001-06-01), None
patent: WO0154498 (2001-08-01), None
patent: WO0170684 (2001-09-01), None
patent: WO0172705 (2001-10-01), None
patent: WO0200653 (2002-01-01), None
patent: WO0107052 (2002-02-01), None
patent: WO0218335 (2002-03-01), None
patent: WO03011824 (2003-02-01), None
patent: WO03066636 (2003-08-01), None
Nicolaou et al., Journal of the American Chemical Society, 2002, vol. 124, No. 10, p. 2233-2244.
Boeijen et al., Bioorg. Med. Chem. Lett. 8:2375-2380.
Beyler et al., J. Am. Med. W. Assoc., 23(8):708-721.
Boris et al., Steroids, 15:61-71.
Bundgaard, “Design of Prodrugs”, Elsevier Science Publishers 1985, tabe of contents.
Bundgaard, “Design and Application of Prodrugs”, Harwood Academic Publishers 1991, pp. 113-191.
Chalepakis et al., Cell, 53:371-382.
Delaisi et al., J. Steroid Biochem. Molec. Biol. 41(3-8)773-7.
Dyatkin Tet Lett 38(12):2065-6.
Edwards et al., Bioorg. Med. Chem. Lett 9:1003-8.
Issartel et al., 1996, CAS 125:316198.
Lalezari et al., J Het Chem 20(2) 483-485 (1983).
Palovich et al., 2000, CAS 134:25357.
Panouse et al., Ann. Pharm. Franc., 2000:291-302.
Rodbard in Ligand Assay, Masson Publishing USA Inc., 1981, pp. 45-101.
Wermuth et al. in The Practice of Medicinal Chemistry, Academic Press, 1996, pp. 671-696.
Banker et al., “Modern Pharmaceutices, 3rd ed.”, Marcel Dekker, New York, 1996, pp. 451 and 596.
Montes de Oca et al., Arkivoc, 390-403 (2003).
Smigel, K., J. Natl. Cancer Inst., 90(9):647-648 (1998).
Tanenbaum, D.M. et al., Proc. Natl. Acad. Sci. USA, 95:5998-6003 (1998).
Taplin, M.E. et al., J. Cell Biochem., 91(3):483-490 (2004).
Vegeto, E. et al., Cell, 69:703-713 (1992).
Wolft, M.E., ed., Burger's Medicinal Chemistry and Drug Discovery, Fifth Edition, vol. 1, John Wiley & Sons, Inc., pp. 975-977 (1995).
Grese, T.A. et al., Proc. Natl. Acad. Sci. USA, 94:14105-14110 (1997).
Hamann, L.G. et al., J. Med. Chem., 41(4):623-639 (1998).
Hempstock, J. et al., Brit. J, Urology, 82:560-563 (1998).
Neri, R. et al., Endocrinology, 91(2):427-437 (1972).
Quella, S.K. et al., J. Clin. Oncol., 18(5):1068-1074 (2000).
Regal, J.F. et al., P.S.E.B.M., 223:372-378 (2000).
Shiau, A.K. et at., Cell, 95:927-937 (1998).
Hamann, L.G. et al., J. Med. Chem., 42(2):210-212 (1999).
Gori, Z. et al., Boll. Soc. Ital. Biol. Sper., 42:1596-1599 (1966).
Gori, Z. et al., Boll. Soc. Ital. Biol. Sper., 42:1600-1601 (1966).
Heiser, W.C., Meth. Mol. Biol., 130:117-134 (2000).
Hempstock, J. et al., J. Med. Food, 2(3-4):243-246 (1999).
Hershberger, L.G. et al., P.S.E.B.M., 83:175-180 (1953).
Hiraoka, D. et al., Cancer Res., 47:6560-6564 (1987).
Imakura, Y. et al., Chem Pharm. Bull., 40(7)1691-1696 (1992).
Iseki, K. et al., Tetrahedron, 53(10):3513-3526 (1997).
Johannsson, G. et al., J. Clin. Endocr. Metab., 82(3):727-734 (1997).
Kakigami, T. et al., Chem. Pharm. Bull., 46(1):42-52 (1998).
Matsuki, K. et al., Chem. Pharm. Bull., 42(1):9-18 (1994).
Milata, V. et al., Org. Prep. Proc. Intl., 25(6):703-704 (1993).
Minesita, T. et al., Cancer Res., 25:1168-1175 (1965).
Navone, N. M. et al., Clin. Cancer Res., 3:2493-2500 (1997).
Okuda, Y. et al., J. Urology, 145:188-191 (1991).
Schuur, E.R. et al., J. Biol. Chem., 271(12):7043-7051 (1996).
Suzuki, T. et al., J. Steroid Biohem. Molec. Biol., 37(4):559-567 (1990).
Talon, S. et al., Br. J. Pharmacol., 134(7):1523-1531 (2001).
Uozumi, Y. et al., Tetrahedron Letters, 42:407-410 (2001).
Uozumi, Y. et al., Tetrahedron Letters, 42:411-414 (2001).
Venable, J.H., Am. J. Anat., 119:263-270 (1966).
Banz, W.J. et al., J. Med. Food, 2(3-4):271-273 (1999).
Bourguet, W. et al., Nature, 375:377-382 (1995).
Brzozowski, A.M. et al., Nature, 389:753-758 (1997).
Evans, R.M., Science, 240:889-895 (1988).
Labrie, F., Intl. Braz. J. Urol., 30(1):3-11 (2004).
Hamann Lawrence
Li James J.
Wang Haixia
Bristol--Myers Squibb Company
Chu Yong
Gibbons Maureen S.
LandOfFree
Bicyclic compounds as modulators of androgen receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic compounds as modulators of androgen receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic compounds as modulators of androgen receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4237550